Hosp Community Psychiatry 45:261-264, March 1994
© 1994 American Psychiatric Association
|
| | |
|
Savings in Hospital Bed-Days Related to Treatment With Clozapine
William H. Reid M.D., M.P.H.1,
Mark Mason M.S.2, and
Marcia Toprac Ph.D.2
1 Texas Department of Mental Health and Mental Retardation, P.O. Box 12668, Austin, Texas 78711; National Association of State Mental Health Program Directors
2 Texas Department of Mental Health and Mental Retardation
Objective: The authors' aim was to determine whether clozapine was associated with a decrease in state hospital bed-days for patients with chronic schizophrenia. Methods: Patients were started on clozapine in a state facility and were followed while taking the medication for 1.5 years (N=172), two years (N=86), and 2.5 years (N=53). Patients' number of bed-days before starting clozapine was compared with those during the follow-up period. Results: Bed-days were reduced by an average of 132 days per year after 1.5 years, 166 days per year after two years, and 201 days per year after 2.5 years (p < .001). During the final 180 days of eacb follow-up period, only 23 to 30 percent of patients were continuously hospitalized, compared with 56 to 64 percent before clozapine. Forty to 57 percent of patients had no hospital days at all during the last 180 days of follow-up. Conclusions: Based on hospital costs of $250 per patient per day, this reduction in bed-days could result in gross savings of about $33,000 per patient per year at 1.5 years, $41,500 per patient per year at two years, and $50,250 per patient per year at 2.5 years. Hospital patients are conspicuous targets for clozapine funding, since bed-days represent an easily measured expense. Nevertheless, cornmunity treatment should be an even higher priority, since most chronic mentally ill persons are outpatients.
This article has been cited by other articles:
|
|
|
|
 
N. Blieden, S. Flinders, K. Hawkins, M. Reid, L. D. Alphs, and C. L. Arfken
Health Status and Health Care Costs for Publicly Funded Patients With Schizophrenia Started on Clozapine
Psychiatr Serv,
December 1, 1998;
49(12):
1590 - 1593.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Reid, M. Mason, and T. Hogan
Suicide Prevention Effects Associated With Clozapine Therapy in Schizophrenia and Schizoaffective Disorder
Psychiatr Serv,
August 1, 1998;
49(8):
1029 - 1033.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. J. Luchins, P. Hanrahan, M. Shinderman, L. Lagios, and C. G. Fichtner
Initiating Clozapine Treatment in the Outpatient Clinic: Service Utilization and Cost Trends
Psychiatr Serv,
August 1, 1998;
49(8):
1034 - 1038.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. N. Ghaemi, D. M. Ziegler, T. J. Peachey, and F. K. Goodwin
Cost-Effectiveness of Clozapine Therapy for Severe Psychosis
Psychiatr Serv,
June 1, 1998;
49(6):
829 - 831.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rosenheck, J. Cramer, W. Xu, J. Thomas, W. Henderson, L. Frisman, C. Fye, D. Charney, and The Department of Veterans Affairs Cooperative Stu
A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia
N. Engl. J. Med.,
September 18, 1997;
337(12):
809 - 815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Davis, W. E. Lowell, and G. L. Davis
Measuring Quality of Care in a Psychiatric Hospital Using Artificial Neural Networks
American Journal of Medical Quality,
March 1, 1997;
12(1):
33 - 43.
[Abstract]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1994
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
